Adam Kelliher is a successful entrepreneur with a strong marketing background and a track record of creating and building life science companies. He founded Equateq in 2006, a cGMP-certified manufacturer providing super-pure fatty acids for the nutritional, pharmaceutical and research sectors which was sold to BASF in 2012. Mr Kelliher received a Master of Arts from the University of Auckland and is a graduate of the Entrepreneurial Development Program at the Massachusetts Institute of Technology, Sloan School of Management.